FDA: Consumer Warning for Weight Loss Supplement

The U.S. Food and Drug Administration (FDA) recently issued a consumer warning for the weight loss supplement MAXILOSS Weight Advanced.

The FDA found traces of sibutramine in the supplement. Sibutramine is an appetite suppressant drug that was withdrawn from the market in 2010. Thus, MAXILOSS Weight Advanced is considered an unapproved drug. This supplement has been sold online and in retail stores.

In November 2012, the FDA found sibutramine in three other weight loss supplements: Japan Hokkaido Slimming Weight Loss Pills, Beautiful Slim Body and Best Share Green Coffee: Brazilian Slimming Coffee. In December 2012, sibutramine was also discovered in Slimdia Revolution.

Sibutramine can raise blood pressure and heart rate, causing potential complications in individuals with heart disease, heart failure, arrhythmias or stroke. Sibutramine may also interact adversely with prescription drugs.

Any consumer in possession of MAXILOSS Weight Advanced should discard the product immediately. Any negative side effects should be reported to a healthcare provider and the FDA's MedWatch Safety Information and Adverse Event Reporting Program.

For more information about integrative therapies for weight loss, please visit Natural Standard's Comparative Effectiveness Database.

References

1. Natural Standard: The Authority on Integrative Medicine. 
   
2. US Food and Drug Administration. www.fda.gov